Measuring muscle relaxant duration in infants during skull surgery
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system, Injuries & trauma clinical trials.
This trial tests how long a muscle relaxant (rocuronium) works in infants aged 3-12 months having skull surgery for a condition called craniosynostosis. The results may help doctors give safer and more effective doses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between 3 and 12 months old
- Your baby will have surgery to treat craniosynostosis (a condition where skull bones fuse too early)
- You have given written permission for your baby to join this study
- Your baby does not have muscle or nerve diseases, or severe liver or kidney problems
- Your baby is not allergic to any of the medicines used in the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called sugammadex, which is used to reverse the effects of a muscle relaxant given during anesthesia. It is for adults having general or brain surgery, and aims to help you wake up and breathe more quickly after surgery.
This trial tests a way to reverse the effects of a muscle relaxant used during surgery, aiming to help you recover breathing and muscle control faster after anesthesia.
This study tests a new way to check how well muscle relaxants are working in intensive care patients. It aims to make sure the monitoring is reliable, which could help doctors adjust treatment better for each patient.
This trial tests two different medicines used to reverse muscle relaxation after lung surgery. It looks at which one helps you breathe better in the first hours after your procedure.
This study is testing how the depth of muscle relaxation during anesthesia affects your breathing during and after open abdominal surgery. The goal is to find the best approach to reduce breathing complications after surgery.
This study compares a new muscle relaxant medication with a standard one to see how well they work for placing a breathing tube and maintaining muscle relaxation during surgery. It aims to find a safer or more effective option for patients undergoing general anesthesia.
Hear when a new Neuromuscular Blocking Agents trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.